Capricor Therapeutics (CAPR) Revenue Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) Revenue Growth (1y) (2012 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
37.90% |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-7.92% |
| Sep 30, 2024 |
-63.44% |
| Jun 30, 2024 |
1.38% |
| Mar 31, 2024 |
234.82% |
| Dec 31, 2023 |
1,159.30% |
| Sep 30, 2023 |
288.66% |
| Jun 30, 2021 |
309.28% |
| Mar 31, 2021 |
-78.02% |
| Dec 31, 2020 |
-73.96% |
| Sep 30, 2020 |
-88.13% |
| Jun 30, 2020 |
-87.85% |
| Mar 31, 2020 |
-19.44% |
| Dec 31, 2019 |
-65.73% |
| Sep 30, 2019 |
-35.20% |
| Jun 30, 2019 |
1.58% |
| Mar 31, 2019 |
-42.38% |
| Dec 31, 2018 |
36.21% |
| Sep 30, 2018 |
-30.01% |
| Jun 30, 2018 |
29.11% |
| Mar 31, 2018 |
-54.58% |
